Cargando…
The Ligand-binding Domain of CD22 Is Needed for Inhibition of the B Cell Receptor Signal, as Demonstrated by a Novel Human CD22-specific Inhibitor Compound
CD22 is a B cell–specific transmembrane protein of the Siglec family. It binds specifically to α2,6-linked sialic acid (Sia) residues, which are also present on glycoproteins on the B cell surface. CD22 acts as a negative regulator in B cell receptor–mediated signaling by recruitment of Src homology...
Autores principales: | Kelm, Soerge, Gerlach, Judith, Brossmer, Reinhard, Danzer, Claus-Peter, Nitschke, Lars |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193707/ https://www.ncbi.nlm.nih.gov/pubmed/11994426 http://dx.doi.org/10.1084/jem.20011783 |
Ejemplares similares
-
Identification of CD22 Ligands on Bone Marrow Sinusoidal Endothelium Implicated in CD22-dependent Homing of Recirculating B Cells
por: Nitschke, Lars, et al.
Publicado: (1999) -
Sialic Acid Binding Domains of CD22 Are Required For Negative Regulation of B Cell Receptor Signaling
por: Jin, Lei, et al.
Publicado: (2002) -
Inhibition of the B Cell by CD22: A Requirement for Lyn
por: Smith, Kenneth G.C., et al.
Publicado: (1998) -
CD8β Increases CD8 Coreceptor Function and Participation in TCR–Ligand Binding
por: Renard, Valery, et al.
Publicado: (1996) -
The Modulation of CD40 Ligand Signaling by Transmembrane CD28 Splice Variant in Human T Cells
por: Mikolajczak, Sebastian A., et al.
Publicado: (2004)